GLP1R and metabolic dysfunction-associated steatotic liver disease: This is because GLP-1 RAs have shown various benefits in managing non-alcoholic fatty liver disease (NAFLD), alleviating hepatic inflammation, metabolic dysfunction, insulin resistance and lipotoxicity [171-173].